Author Archives: Henry I. Miller

Perspective: FDA Overreach on Genetically Engineered Animals


This article is in Preparing for the Next Flood, Spring 2018


The oft-quoted quip “To a man with a hammer, everything looks like a nail” anticipated the practice of federal agencies expanding their mandate by shoehorning policy initiatives into regulatory regimes for which they were never intended. This practice seems to run contrary to Article I of the US Constitution, which vests all legislative power in […]

The Science of Biotechnology Meets the Politics of Global Regulation


This article is in The Global Battle over Biotech Foods, Fall 2000


Global regulation should be guided by science, not unsubstantiated fears. These are difficult times for agricultural biotechnology. Outside the United States, there is widespread public and political opposition to importing grains grown from recombinant DNA­engineered, or “gene-spliced,” seeds. Governments have imposed moratoriums on commercial-scale cultivation of plants, and recombinant DNA­derived foods have been banished by […]

Forum


This article is in Flaws In Forensic Science, Fall 2003


Federal R&D: More balanced support needed Thomas Kalil (“A Broader Vision for Government Research,” Issues, Spring 2003) is correct that the missions of agencies with limited capacities to support research could be advanced significantly if Jeffersonian research programs were properly designed and implemented for those agencies. However, certain goals and objectives, such as winning the […]

Agricultural Biotechnology: Overregulated and Underappreciated


This article is in Computing Solutions to Airline Safety and Other Policy Dilemmas, Winter 2005


The pursuit of an integrated action plan, including regulatory reform, will help the United States and the world reap enormous benefits that now are thwarted. The application of recombinant DNA technology, or gene splicing, to agriculture and food production, once highly touted as having huge public health and commercial potential, has been paradoxically disappointing. Although […]

DEE-FENSE! DEE-FENSE!: Preparing for Pandemic Flu


This article is in Energy Conundrums, Summer 2006


Federal research, economic incentives for industry, and a more responsive regulatory regime will all be necessary to produce a timely and widely available vaccine. Vaccination to prevent viral and bacterial diseases is modern medicine’s most cost-effective intervention. Were a vaccine to be available quickly after the onset of the widely predicted pandemic from an H5N1 […]

Forum


This article is in The Road to a New Energy System, Fall 2009


Too few fish in the sea Carl Safina’s review of how traditional fisheries management strategies have failed both the fish and the fishermen is right on target, as are his recommendations for new management strategies (“A Future for U.S. Fisheries,” Issues, Summer 2009). But I encourage all of us who think about the ocean to […]

Book Review: Drug Kingpin


This article is in The Need for Geoengineering Research, Fall 2010


Drug Kingpin Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA by Daniel Carpenter. Princeton, NJ: Princeton University Press, 2010, 856 pp. Henry I. Miller Daniel Carpenter’s magnum opus about the origins, operations, and organizational nuances of the Food and Drug Administration (FDA) represents in many respects superb historical scholarship. A former chief […]

Give Genetic Engineering Some Breathing Room


This article is in Has NIH Lost Its Halo?, Winter 2015


Government regulations are suffocating applications that promise much public benefit. Fixes are available, if society and policymakers would only pay heed to science. New genetic engineering techniques that are more precise and versatile than ever offer promise for bringing improved crops, animals, and microorganisms to the public. But these technologies also […]